Intalfa 3MIU Injection contains Interferon Alfa-2b, a synthetic form of a protein that occurs naturally that helps the immune system fight infections and certain cancers.

Composition: Interferon Alfa-2b

Mechanism of Action:

By preventing virus replication, regulating immune system function, and halting tumor cell growth, interferon Alfa-2b strengthens the immunological response. These processes improve the body's ability to combat infections and some malignancies.

Uses:

·       Chronic Hepatitis B and C infections

·       Hairy cell leukemia

·       Follicular lymphoma

·       Multiple myeloma

Dosage and Administration:

Given by intramuscular or subcutaneous injection. The dosage varies according to the illness; for chronic hepatitis B, 5 million IU per day or 10 million IU three times a week for 16 weeks is the usual dosage.

Side Effects:

·       Headache

·       Dizziness

·       Blurred vision

·       Insomnia

·       Nausea

·       Vomiting

·       Fatigue

·       Fever

·       Flu-like symptoms

·       Mood changes

·       Anxiety

·       Depression

Safety Advise:

Lungs  

The safety of Intalfa Injection for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Intalfa Injection for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Intalfa Injection for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Intalfa should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Intalfa while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Keep in a refrigerator at 2°C to 8°C. Avoid freezing. Store in its original packaging and shield from light.

How to use this Medication?

Interferon alfa-2b is available as a solution to inject subcutaneously (just beneath the skin), intramuscularly (into a muscle), intravenous (into a vein), or intralesionally (into a lesion) or as a powder in a vial to mix with liquid. On your injection days, it is ideal to administer the drug at roughly the same time of day, which is typically in the late afternoon or evening.

References:

1.   Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP. Treatment of acute hepatitis C with interferon alfa-2b. New England Journal of Medicine. 2001 Nov 15;345(20):1452-7.

2.  Kluin-Nelemans HC, Jansen JH, Breukelman H, Wolthers BG, Kluin PM, Kroon HM, Willemze R. Response to interferon alfa-2b in a patient with systemic mastocytosis. New England Journal of Medicine. 1992 Feb 27;326(9):619-23.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Intas Pharmaceuticals Ltd

Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Country of origin: India